Angel Biotechnology Holdings plc ABH Pharmaceuticals Healthcare Deals and Alliances Profile

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Biologic Therapeutic Drugs: Technologies and Global Markets

Biologic Therapeutic Drugs: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • by BCC Research
  • Dec 2014
  • 172 pages

REPORT HIGHLIGHTS The global biologics market totaled $200.6 billion in 2013 and is expected to grow to nearly $234 billion in 2014. The total market is expected to grow to $386.7 billion by the end of 2019 at compound annual growth rate (CAGR) of 10.6%. This report provides: An overview of the global ...

Industries: Biopharmaceutical | Countries: World

Renal Biomarkers: Technologies and Global Markets

Renal Biomarkers: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • by BCC Research
  • Dec 2014
  • 90 pages

REPORT HIGHLIGHTS The in vitro diagnostic renal biomarker market was valued at $771 million in 2013 and $812 million in 2014. The market is expected to reach $1.1 billion by 2019, a compound annual growth rate (CAGR) of 7% from 2014 to 2019. This report provides: A comprehensive analysis of renal biomarkers ...

Industries: Genomics | Countries: World

Antibody Drugs: Technologies and Global Markets

Antibody Drugs: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • by BCC Research
  • Dec 2014
  • 141 pages

REPORT HIGHLIGHTS The global market for antibody drugs was worth nearly $63.4 billion in 2013. This market is expected to grow at a compound annual growth rate (CAGR) of 12.2% between 2014 and 2019 resulting in totals nearly $68.9 billion in 2014 and $122.6 billion globally in 2019. This report provides: ...

Industries: Biopharmaceutical | Countries: World

Biosimilars Business Review Q4 2014

Biosimilars Business Review Q4 2014

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • December 2014
  • 16 pages

Industry Trend Analysis - US Biosimilar Market Edged Closer In 2014, Intensifying Key Debates Industry Brief - Epirus Enters China Collaboration With Livzon Industry Trend Analysis - Amgen's Biosimilar Programme Progresses Industry Brief - STADA In-Licenses Biosimilar Teriparatide Industry Brief - Baxte ...

Industries: Biopharmaceutical | Countries: India, China, United States, World

Peptidream Inc

Peptidream Inc

  • $ 55
  • Company report
  • by Wright Investors' Service
  • December 2014
  • 54 pages

A textual analysis of the financial results for Peptidream Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description ...

Industries: Biological Therapy | Countries: Japan

Chenguang Biotech Group Company Limited

Chenguang Biotech Group Company Limited

  • $ 55
  • Company report
  • by Wright Investors' Service
  • December 2014
  • 54 pages

A textual analysis of the financial results for Chenguang Biotech Group Company Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. ...

Industries: Biotechnology

PCI Biotech Holding ASA

PCI Biotech Holding ASA

  • $ 55
  • Company report
  • by Wright Investors' Service
  • December 2014
  • 55 pages

A textual analysis of the financial results for PCI Biotech Holding ASA compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description ...

Industries: Biotechnology

Quantrx Biomedical Corporation

Quantrx Biomedical Corporation

  • $ 55
  • Company report
  • by Wright Investors' Service
  • December 2014
  • 56 pages

A textual analysis of the financial results for Quantrx Biomedical Corporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Biopharmaceutical

JiangXi ChangJiu Biochemical Industry Company Limited

JiangXi ChangJiu Biochemical Industry Company Limited

  • $ 55
  • Company report
  • by Wright Investors' Service
  • December 2014
  • 55 pages

A textual analysis of the financial results for JiangXi ChangJiu Biochemical Industry Company Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and ...

Industries: Biotechnology

Medicamen Biotech Limited

Medicamen Biotech Limited

  • $ 55
  • Company report
  • by Wright Investors' Service
  • December 2014
  • 54 pages

A textual analysis of the financial results for Medicamen Biotech Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Biotechnology | Countries: India

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.